HealthBeacon to present at 9th annual Biotech Showcase in San Francisco
IoT company, HealthBeacon, a leading medical adherence provider will present at the 9th annual Biotech Showcase in San Francisco.
Dublin, Ireland (January 9th, 2017)
A leader in the development of medical adherence solutions for injectable medications, today announced that it is scheduled to present at the 9th Annual Biotech Showcase, being held on January 9-11, 2017 at the Hilton San Francisco Union Square in San Francisco.
Jim Joyce, Chief Executive Officer, will provide an update of the Company’s business during the live presentation and will be available for face-to-face conversations with conference attendees. Details for the presentation are as follows: Date: Wednesday, January 11, 2017 Time: 8:00AM PST.
HealthBeacon is an Irish-based IoT company developing a digital health platform connecting devices and data for better health delivery. Visit Website >
HealthBeacon, founded in 2014 by both Jim Joyce, serial healthcare entrepreneur, and Kieran Daly, former CEO of Shimmer, developed its first device – to help patients on self injectable medication adhere to their medical schedules.
Medical adherence, helping patients comply with treatment regimens is one of the largest problems facing healthcare systems. Evidence suggests that patients on average comply with their medicine schedules only 50-70% of the time. The pharmaceutical market for patients who self administer medicines by injections is estimated to be over €40b.
Millions of patients worldwide treat devastating chronic diseases like diabetes, multiple sclerosis, arthritis, gastro conditions, and heart disease by self administering injections in their home. Unfortunately, many of these patients struggle to comply with their treatment.
The HealthBeacon team has designed a device that knows when a patient has taken their medication and critically if they have forgotten, or missed a dose. If they miss an injection, their HealthBeacon will send a simple reminder to their phone. The result is potentially a more compliant and healthier patient.
“HealthBeacon is a significant advancement in the management of self injectable medications, we can now have confidence that a patient has taken their medication on time when in the home”, said Professor Douglas Veale, Consultant Rheumatologist, Adjunct Professor of Medicine, University College Dublin.
HealthBeacon’s digital platform exploits the increased trend in healthcare to connect devices and data for better health delivery. The internet of things (IoT) trend will drive fast adoption and scaling of the platform, especially as it supports lower cost health delivery in the community of patients who previously were only administered their treatment in hospital.
For further information please contact: Brie Kelly